ISSN: 1759-4774

Journal Home

Journal Guideline

Nature Reviews Clinical Oncology Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Clinical Oncology is a journal indexed in SJR in Oncology with an H index of 142. It has an SJR impact factor of 9,882 and it has a best quartile of Q1.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

9,882

SJR Impact factor

142

H Index

176

Total Docs (Last Year)

591

Total Docs (3 years)

7645

Total Refs

6087

Total Cites (3 years)

287

Citable Docs (3 years)

23,16

Cites/Doc (2 years)

43,44

Ref/Doc

Aims and Scope

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of the National Cancer Institute Q1
Clinical Cancer Research Q1

Best articles

A case of variant angina in a patient under chronic treatment with sorafenib

A promising vaccine for glioblastoma multiforme

Abiraterone treatment improves overall survival in patients with mCRPC

ADAM8 provides new hope in pancreatic cancer

Advanced Hodgkin lymphoma - balancing toxicity and cure

ALL: reducing cardiomyopathy

ARAMIS - is darolutamide set to become the 'third musketeer' of nmCRPC?

Biomarker potential of CA-125 enhanced

Bortezomib and dexamethasone induction for multiple myeloma

BRAF and MEK inhibitors - good news comes in twos!

Can less really be more in melanoma?

Celebrating 10 years since launch

SHOW MORE ARTICLES

Cetuximab's tip to become irresistible

Cisplatin more effective when given less often

CONKO conquers

Conscripts of the infinite armada: systemic cancer therapy using nanomaterials

CRISPR-Cas: a tool for cancer research and therapeutics

CSF DNA provides a snapshot of the glioma genome

CTCs - a predictive approach for targeted cancer therapy

Dacomitinib: getting on target after negative ARCHER trial

Does nodal micrometastasis impact outcome in biliary cancer?

Driver genes are mutated early in the course of oesophageal adenocarcinoma

Erratum: Clinical trials of human papillomavirus vaccines and beyond

Erratum: Managing bone metastases and reducing skeletal related events in prostate cancer

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.